S&P 500 Futures
(0.19%) 5 141.00 points
Dow Jones Futures
(0.18%) 38 509 points
Nasdaq Futures
(0.26%) 17 893 points
Oil
(-0.91%) $83.09
Gas
(1.82%) $1.958
Gold
(0.04%) $2 348.10
Silver
(0.10%) $27.56
Platinum
(0.52%) $926.85
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.16%) $11.01
USD/GBP
(-0.27%) $0.798
USD/RUB
(1.11%) $92.89

实时更新: InspireMD Inc [NSPR]

交易所: AMEX 工业: Medical Devices
最后更新时间27 Apr 2024 @ 04:00

5.82% $ 2.00

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific...

Stats
今日成交量 10 238.00
平均成交量 34 706.00
市值 46.80M
EPS $0 ( 2024-04-04 )
下一个收益日期 ( $-0.150 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.44
ATR14 $0.0220 (1.10%)
Insider Trading
Date Person Action Amount type
2024-01-23 Kester Thomas J Buy 29 032 Common Stock
2024-01-23 Kester Thomas J Buy 11 098 Options to purchase common stock (right to buy)
2024-01-23 Verta Patrick Buy 85 720 Common Stock
2024-01-23 Verta Patrick Buy 32 768 Options to purchase common stock (right to buy)
2024-01-23 Gleason Shane Thomas Buy 238 625 Common Stock
INSIDER POWER
98.06
Last 99 transactions
Buy: 7 620 190 | Sell: 72 371

InspireMD Inc 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

InspireMD Inc 财务报表

Annual 2023
营收: $6.21M
毛利润: $1.81M (29.12 %)
EPS: $-0.820
FY 2023
营收: $6.21M
毛利润: $1.81M (29.12 %)
EPS: $-0.820
FY 2022
营收: $5.17M
毛利润: $1.12M (21.60 %)
EPS: $-2.35
FY 2021
营收: $4.50M
毛利润: $754 000 (16.77 %)
EPS: $-2.03

Financial Reports:

No articles found.

InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。